Congratulations to our partners at Johnson & Johnson MedTech / DePuy Synthes and Ortoma AB on delivering this innovative technology to the market for the benefit of patient outcomes and all stakeholders involved.
MedWorld Advisors serves as advisor to Vascular Technology, Inc, a medical device company specializing in innovative surgical devices and single-use consumables for the operating room, in their sale to middle market PE firm JLL Partners.
Explore how MedTech companies can build long-term intrinsic value through market strategy, financial health, culture, and innovation.
As shown in past economic cycles, M&A will serve as an avenue to adapt to these changes and increase sustainability for businesses and customers alike.
When it comes to your business, value isn’t just about numbers. It’s about what lies beneath. Managing Director Dave Sheppard speaks to building intrinsic value in your medtech manufacturing business on the Moore on Manufacturing podcast.
The current tariff environment underscores the importance of agility, adaptability, and strategic foresight in maintaining and enhancing competitive leadership.
Learn more about how current trade policies and tariffs on medical devices are shaking up U.S. medical device manufacturing.
Good news drives M&A activity and bad news is tolerable as long as it is understood, but uncertainty is the main nemesis of growth.
Factors contributing to manufacturing’s continuous evolution include reproducible, high-quality, AI-enabled technologies; higher product demand; and cost pressures.
These transactions – where companies spin off, sell, or reallocate parts of their business – reshape portfolios, redefine priorities, and unlock value across the healthcare ecosystem.